Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
Sarepta Therapeutics said it will announce first quarter 2026 financial results. The event will be webcast on its investor relations website, with a replay archived for one year.
Sarepta Therapeutics to announce first quarter 2026 financial results. The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations, and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form.
After registering for dial-in details, all phone participants will receive an auto-generated e-mail containing a link to the dial-in number along with a personal PIN number to use to access the event by phone.
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. The company holds a leadership position in Duchenne muscular dystrophy and is building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases.
The company routinely posts information that may be important to investors in the 'For Investors' section of its website at www.sarepta.com and encourages investors and potential investors to consult the website regularly for important information.